NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Caribou Biosciences, Inc. CRBU: (i) pursuant to and/or traceable to the offering documents and related prospectus issued in connection with the Company’s 2021 initial public offering, conducted on or about July 23, 2021 (the “IPO” or the ” Offer”); and/or (ii) between July 23, 2021 and December 9, 2022, both dates inclusive (the “Class Period”). If you want to appear as lead plaintiff, you must call the court by April 11, 2023 at the latest.

SO WHAT: If you purchased Caribou Securities during the Class Period, you may be entitled to compensation without payment of expenses or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To participate in the Caribou fundraiser, go to https://rosenlegal.com/submit-form/?case_id=11988 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email pkim@rosenlegal.com or cases@rosenlegal.com for information about the Class Action. A class action lawsuit has already been filed. If you want to appear as lead plaintiff, you must call the court by April 11, 2023 at the latest. A lead plaintiff is a representative party acting on behalf of other group members in conducting the litigation.

WHY ROSES LAW: We encourage investors to select qualified advisors with a track record in leadership positions. Frequently, companies that issue notices do not have comparable experience, resources, or meaningful recognition from peers. Be wise in choosing a lawyer. The Rosen law firm represents investors worldwide and focuses its practice on securities class actions and shareholder derivatives litigation. Rosen Law Firm has achieved the largest-ever securities class-action settlement against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The law firm was ranked #1.